Stay updated on SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.3%
    Check dated 2025-07-18T10:46:40.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page now includes a service alert about planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours. Additionally, the version has been updated from v2.16.4 to v2.16.5.
    Difference
    8%
    Check dated 2025-07-11T03:48:00.000Z thumbnail image
  3. Check
    23 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    3%
    Check dated 2025-06-19T19:23:02.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.3%
    Check dated 2025-06-05T11:05:28.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-29T05:52:31.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-04-30T13:51:48.000Z thumbnail image

Stay in the know with updates to SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page.